Press release |

BEITEN BURKHARDT Advises Aesculap AG on Acquisition of Majority Interest in SCHÖLLY FIBEROPTIC GmbH

Hamburg, 19 April 2021 – The international law firm BEITEN BURKHARDT has advised Aesculap AG on the acquisition of a majority of business shares in SCHÖLLY FIBEROPTIC GMBH from the Schölly family. The Schölly family holds an interest of 30 percent. The transaction is subject to the customary closing conditions. The parties have agreed not to disclose the transaction volume.

SCHÖLLY FIBEROPTIC GMBH is a globally active medical engineering company, headquartered in Denzlingen, Germany. The company focuses on the engineering and production of customized visualization systems for the business areas medical endoscopy and visual inspection. Aesculap AG and SCHÖLLY FIBEROPTIC GmbH have been working together in the field of endoscopic visualization since 1989. Since 1998 Aesculap AG has been a shareholder in SCHÖLLY FIBEROPTIC GmbH. The best known example of their cooperation is the 3D visualization system EinsteinVision®.

"We are pleased to continue our excellent cooperation and to position ourselves even more strongly together in the market with our innovations," comments Dr Joachim Schulz, Chairman Management Board at Aesculap AG.

Aesculap is part of the B. Braun group and is one of the globally leading provider of medical engineering products and services.

Advisors to Aesculap AG:

BEITEN BURKHARDT: Partners Dr Christian Ulrich Wolf (Corporate/M&A); Dr Marion Frotscher (Tax); Jan Christian Eggers (Antitrust Law, all Hamburg); Dr Andreas Lober (IP/IT, Frankfurt am Main); Associate Chiara Stubenrauch (Corporate/M&A, Hamburg).

Inhouse: Dr Sebastian Braun-Lüdicke (Vice President Legal Affairs); Dr Christian Müller (Senior Legal Counsel).

The merger notification in Austria was prepared and filed in cooperation with Schönherr Rechtsanwälte.

Dr Christian Ulrich Wolf
Phone.: +49 40 68 87 45 – 124